CD274 and glioblastoma: The aim of the study was to assess TILs, TAMs and immunomodulatory targets (PD-1 and PD-L1) in the GBM microenvironment to evaluate their prognostic role in adaptive-cell-mediated immunity and to investigate their interplay with other clinicopathological and molecular features for determining GBM prognosis.